DAPZURA RT FDA approval date
The FDA approved DAPZURA RT on 25 Jan 2022.
- FDA approval date
- 25 Jan 2022
- Source
- FDA record
Drug identity has not yet been verified against registry records
Also recorded as DAPTOMYCIN
Included trials
No linked trials for this drug yet. Browse all trials
PDUFA dates and FDA decisions
| Date as reported | Drug / company | Event | Condition | Evidence |
|---|---|---|---|---|
| 2022-01-25Day | DAPZURA RT | FDA original application approvalFDA approval decision | Not specified | Open original sourceRead source excerpt{"application_number": "NDA213645", "applicant_as_listed_by_fda": "BAXTER HLTHCARE CORP", "brand_names": ["DAPTOMYCIN IN 0.9% SODIUM CHLORIDE", "DAPZURA RT"], "active_ingredients": ["DAPTOMYCIN"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220125", "matched_on": "drug record created from this FDA brand name"} First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026 |